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 ABSTRACT During constitutive secretion, proteins synthesized at the endoplasmic reticulum 
(ER) are transported to the Golgi complex for processing and then to the plasma membrane 
for incorporation or extracellular release. This study uses a unique live-cell constitutive secre-
tion assay to establish roles for the molecular motor myosin VI and its binding partner op-
tineurin in discrete stages of secretion. Small interfering RNA-based knockdown of myosin VI 
causes an ER-to-Golgi transport delay, suggesting an unexpected function for myosin VI in 
the early secretory pathway. Depletion of myosin VI or optineurin does not affect the number 
of vesicles leaving the  trans -Golgi network (TGN), indicating that these proteins do not func-
tion in TGN vesicle formation. However, myosin VI and optineurin colocalize with secretory 
vesicles at the plasma membrane. Furthermore, live-cell total internal refl ection fl uorescence 
microscopy demonstrates that myosin VI or optineurin depletion reduces the total number of 
vesicle fusion events at the plasma membrane and increases both the proportion of incom-
plete fusion events and the number of docked vesicles in this region. These results suggest a 
novel role for myosin VI and optineurin in regulation of fusion pores formed between secre-
tory vesicles and the plasma membrane during the fi nal stages of secretion. 
 INTRODUCTION 
 Constitutive exocytosis is a fundamental cellular process governing 
the transport of newly synthesized proteins to the cell surface for 
insertion into the plasma membrane or secretion into the extracel-
lular environment. The secretory pathway involves a complex se-
quence of steps dependent on intracellular transport machinery. In 
the fi rst stages of secretion, proteins synthesized by the ribosomes 
of the rough endoplasmic reticulum (ER) are transported in vesicles 
and larger tubular clusters from specifi c ER exit sites to the  cis side 
of the Golgi complex (Saraste and Svensson,  1991 ;  Presley  et al. , 
1997 ). After the proteins are moved through the different compart-
ments of the Golgi complex for posttranslational processing, they 
are sorted at the  trans side of the Golgi complex into tubular or 
vesicular carriers and transported to the plasma membrane for 
exocytosis (Griffi ths and Simons,  1986 ; Keller and Simons,  1997 ). 
The release of secreted proteins into the extracellular space during 
the fi nal stages of secretion requires fusion of juxtaposed phospho-
lipid bilayers of vesicular and plasma membranes to form an aque-
ous channel called a “fusion pore” that expands to permit full pro-
tein release (Jahn and Sudhof,  1999 ). 
 The intracellular transport system that coordinates the different 
stages of the secretory process is driven by carrier proteins called 
molecular motors. Transport by these motors can be divided into 
the short-range movements of myosin molecular motors along actin 
fi lament tracks and the comparatively faster and longer-ranged 
movements of kinesin and dynein motors along microtubule tracks. 
Within these three classes of motors lies the capacity for transport of 
secretory cargo in all directions within the cell: kinesin proteins pri-
marily move cargo toward the plus ends of microtubules, dynein 
proteins transport cargo toward the minus ends of microtubules, 
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and specifi c myosin protein classes transport to either the plus or 
the minus ends of actin fi laments. Cooperation between the three 
classes of molecular motors is thereby the driving force in the 
organization of traffi cking in secretory transport processes. In addi-
tion to this well-defi ned role in cargo transport, molecular motor 
proteins have also been implicated in the organization of the secre-
tory pathway through regulation of vesicle tethering and budding 
( Rudolf  et al. , 2001 ;  Egea  et al. , 2006 ), cargo sorting and mainte-
nance of morphology at the Golgi complex (Donaldson and Lippin-
cott-Schwartz,  2000 ;  Allan  et al. , 2002 ;  Sahlender  et al. , 2005 ), and 
vesicle docking and fusion pore formation at the plasma membrane 
(Bhat and Thorn,  2009 ;  Chung le  et al. , 2010 ). 
 One such motor protein suggested to function in the secretory 
pathway is myosin VI, which has the unique ability to transport cargo 
toward the minus ends of actin fi laments ( Wells  et al. , 1999 ). Myosin 
VI localizes to vesicles in the perinuclear region at or around the 
Golgi complex ( Buss  et al. , 1998 ;  Warner  et al. , 2003 ) and to vesicles 
close to the plasma membrane ( Sahlender  et al. , 2005 ). Functional 
studies using fi broblasts isolated from the myosin VI knockout 
(Snell’s waltzer) mouse or myosin VI small interfering RNA (siRNA) 
knockdown cells demonstrate a signifi cant reduction in the constitu-
tive exocytosis of a secreted form of alkaline phosphatase (SEAP) 
from cells lacking myosin VI ( Warner  et al. , 2003 ). Furthermore, my-
osin VI is required for the delivery of newly synthesized transmem-
brane proteins to the basolateral plasma membrane domain in po-
larized epithelial cells. In these cells, depletion of functional myosin 
VI by overexpression of the dominant negative tail domain results in 
a missorting of basolateral cargo such as vesicular stomatitis virus 
G-protein (VSV-G) to the apical plasma membrane ( Au  et al. , 2007 ; 
 Chibalina  et al. , 2008 ). These data clearly establish a role for myosin 
VI in secretion, but they provide no insight as to the specifi c involve-
ment of myosin VI throughout the stages of the secretory pathway. 
 The role of myosin VI in the secretory pathway is closely linked 
to its interacting protein optineurin. Optineurin is a 67-kDa dimeric 
protein that colocalizes with myosin VI in the perinuclear region and 
on vesicles beneath the plasma membrane ( Sahlender  et al. , 2005 ). 
siRNA-mediated knockdown of optineurin decreases secretion of 
SEAP and VSV-G in a similar manner to myosin VI depletion ( Sahl-
ender  et al. , 2005 ;  Au  et al. , 2007 ;  Chibalina  et al. , 2008 ). Optineu-
rin not only binds to myosin VI but has also been shown to interact 
with the GTPase Rab8 and with huntingtin, which are important 
regulators of vesicle transport ( Huber  et al. , 1993b ; Hattula and 
Peranen,  2000 ; Caviston and Holzbaur,  2009 ). Recent implications 
that defects in optineurin cause primary open angle glaucoma 
(POAG) ( Rezaie  et al. , 2002 ) and play a role in the pathogenesis of 
amyotrophic lateral sclerosis (ALS) ( Maruyama  et al. , 2010 ) stress 
the importance of investigating its primary intracellular functions. 
 Although previous work has established a role for myosin VI and 
optineurin in constitutive secretion of a variety of transmembrane 
proteins and soluble luminal cargo in both polarized and unpolar-
ized cells, no available studies address the specifi c roles of these 
proteins in the secretory pathway. Therefore, in this study, we inves-
tigate the exact roles of myosin VI and optineurin at each stage of 
constitutive secretion using live-cell fl uorescence microscopy on a 
HeLa cell line stably expressing a green fl uorescent protein (GFP)-
tagged reporter construct ( Gordon  et al. , 2010 ). We are able to dem-
onstrate an unexpected role for myosin VI in the ER-to-Golgi trans-
port stage of secretion, because depletion of myosin VI leads to a 
kinetic delay in cargo transport between the ER and Golgi complex. 
Interestingly, our results further suggest that myosin VI and optineu-
rin are not required for transport carrier formation at the  trans- Golgi 
network (TGN). However, we demonstrate that myosin VI and 
optineurin colocalize with secretory vesicles at the plasma mem-
brane. Furthermore, loss of myosin VI or optineurin dramatically re-
duces the number of cargo vesicles fusing with the plasma mem-
brane and increases both the number of incomplete fusion events 
and the number of docked vesicles at the plasma membrane. Taken 
together, these results suggest a role for myosin VI and optineurin in 
the mechanical regulation of the fusion pore that opens to permit 
protein release in the fi nal stages of the secretory pathway. 
 RESULTS 
 To examine the specifi c roles of myosin VI and optineurin in the se-
cretory pathway, we used a HeLa cell line stably expressing a GFP-
tagged reporter construct ( Gordon  et al. , 2010 ). This reporter con-
struct contains multiple aggregation domains and remains arrested 
in an aggregated form in the ER after synthesis. Binding of the small 
ligand AP21998 (Ariad Pharmaceuticals, Cambridge, MA) to the ag-
gregation domains yields soluble protein, allowing a synchronous 
pulse of GFP-tagged reporter construct to be transported from the 
ER to the Golgi complex and then to the plasma membrane for re-
lease from the cell. This regulated secretion system permits visual-
ization of the main stages of constitutive secretion via live-cell time-
lapse fl uorescence microscopy. 
 Knockdown of myosin VI causes a kinetic delay in 
ER-to-Golgi transport 
 To establish the exact role(s) of myosin VI and optineurin in the secre-
tory pathway, we fi rst investigated the involvement of these proteins 
in the earliest transport-driven stage of secretion: the delivery of syn-
thesized proteins from the ER to the Golgi complex. For this study, 
cells in our assay system were imaged using live-cell spinning disc 
microscopy for a 30-min period immediately following AP21998 treat-
ment to monitor delivery of the GFP-tagged reporter molecule from 
the ER into the Golgi region. The position of the Golgi complex was 
visualized by expressing a red fl uorescent protein (RFP)-tagged β-1,4-
galactosyltransferase-I (GalT) construct. Still images of a video show-
ing movement of the reporter molecule from the ER into the Golgi 
complex in a mock treated cell are shown in the top of  Figure 1A . The 
time-lapse images in the bottom of  Figure 1A display the delay in 
accumulation of cargo in the Golgi region observed in a cell in which 
myosin VI has been depleted with a 5-d, double-hit siRNA knock-
down protocol. At each time point, signifi cantly less GFP-tagged re-
porter molecule is present in the Golgi complex in this myosin VI 
knockdown cell, as compared with the mock cell in the top panel. 
 To quantify the rate of reporter construct transfer from the ER to 
the Golgi complex, Volocity analysis software was used to track the 
accumulation of fl uorescent reporter construct intensity in the re-
gion defi ned as the Golgi complex by the GalT-RFP marker pro-
tein. The fl uorescent intensity present in the Golgi region at each 
time point was converted to a percentage of the total fl uorescent 
intensity in the cell present before addition of AP21998 and plot-
ted versus time to the point of maximum Golgi fl uorescence. The 
slope of this plot represents the rate of reporter construct transport 
from the ER to the Golgi complex. This method was used to calcu-
late the rate of reporter construct transfer between ER and Golgi in 
cells in which myosin VI or optineurin had been depleted by siRNA 
transfection ( Figure 1C ). Optineurin SMARTpool knockdown cells 
show no signifi cant difference in average ER-to-Golgi transport 
rate when compared with mock cells ( Figure 1B ). However, knock-
down of myosin VI with a SMARTpool collection of four siRNA 
primers or with distinct, individual siRNA primers consistently re-
sults in a reduction in ER-to-Golgi transport rate, as compared with 
mock cells (38% overall average rate reduction) ( Figure 1B ). 
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 The number of secretory vesicles 
traveling out of the Golgi complex 
is not changed, however, in myosin VI 
or optineurin knockdown cells 
 To deter mine whether the delay in ER-to-
Golgi protein transfer after depletion of 
myosin VI is propagated to the post-
Golgi stages of the secretory pathway 
and whether myosin VI and optineurin 
are required for vesicle formation at the 
TGN, we next assayed the number of 
vesicles leaving the Golgi complex in 
mock versus myosin VI or optineurin 
knockdown cells. For this analysis, we 
took 1-min, confocal spinning disc vid-
eos of sections through the middle of 
the cell at specifi c intervals between 25 
and 60 min after AP21998 addition. Vesi-
cle tracking software designed at the 
National Institutes of Health and Emory 
University was used to quantify the num-
ber of individual vesicles present in 6 μm × 
6 μm regions between the  trans- Golgi 
and plasma membrane over the course of 
these videos ( Figure 2 ). Com parison of 
mock and siRNA SMARTpool knockdown 
cells reveals that the depletion of myosin 
VI or optineurin results in no signifi cant 
change in the number of vesicles travel-
ing through these regions. This indicates 
that the reduced transport rate between 
the ER and Golgi complex in myosin VI 
knockdown cells is not a rate-limiting 
step in the overall secretory process and 
does not reduce the number of cargo 
vesicles leaving the  trans side of the Golgi 
complex. This enables us to study the 
involvement of myosin VI and optineurin 
in the post-Golgi stages of the pathway 
independently of defects observed in the 
early steps of the secretory pathway. Fur-
thermore, these results suggest that my-
osin VI and optineurin are unlikely to play 
a major role in vesicle formation at the 
TGN as previously speculated (Buss and 
Kendrick-Jones,  2008 ). 
 Myosin VI and optineurin colocalize with secretory vesicles 
at the plasma membrane 
 We examined the involvement of myosin VI and optineurin in the 
later stages of the secretory pathway using total internal refl ection 
fl uorescence (TIRF) microscopy, a technique that permits the selec-
tive illumination of the 100–200-nm region nearest the plasma 
membrane at the base of the cell. Because the localization of op-
tineurin and myosin VI relative to vesicles in this proximity of the 
plasma membrane has not previously been demonstrated, we used 
TIRF microscopy with fi xed, immunofl uorescence-labeled cells to 
examine the distribution of myosin VI and optineurin with respect to 
secretory vesicles in the TIRF fi eld. 
 For these immunofl uorescence studies, HeLa cells stably express-
ing the GFP-tagged reporter construct were treated with AP21998 
and fi xed 35 min after treatment. To examine the localization of 
 As a control, the same rate analysis study was conducted in 
cells depleted of two distinct members of the SNARE family, a 
group of proteins that mediate vesicle docking and fusion 
( Figure 1C ). Knockdown of the vesicle-associated membrane 
protein 7 (VAMP7), a post-Golgi SNARE, has no signifi cant effect 
on ER-to-Golgi transport ( Figure 1B ), which indicates that the de-
lay in transport seen after a knockdown of myosin VI is not simply 
a result of our siRNA knockdown protocol. Knockdown of the 
ER-to-Golgi SNARE syntaxin5, however, completely inhibits ER-
to-Golgi transport ( Figure 1B ), suggesting that a knockdown of 
myosin VI results in a kinetic delay rather than a complete block 
in ER-to-Golgi transport. Overall, our results suggest an unex-
pected role for myosin VI in the transport of cargo between 
the ER and the Golgi complex during the early stages of the 
secretory pathway. 
 FIGURE 1:  Rate of reporter molecule transport from the ER to the Golgi complex. 
(A) Time-lapse images illustrating the accumulation of reporter molecule fl uorescence in the 
Golgi region (as labeled with GalT-RFP) over the fi rst 10 min after AP21998 addition to a mock 
cell (top row) or to a myosin VI knockdown cell (bottom row). (B) Rate of ER-to-Golgi reporter 
molecule transfer in sets of two to eight knockdown cells as a percentage of mock. Knockdown 
of myosin VI with SMARTpool primers (SP), individual primer 1, or individual primer 2 results in 
48, 34, or 33% decreases in ER-to-Golgi transport rate, respectively (unpaired  t test; n = 5, 4, 5 
experimental sets; p = 0.005, p = 3 × 10 −8 , p = 3 × 10 −10 ). Knockdown of optineurin or VAMP7 has 
no signifi cant effect on the rate of ER to Golgi transport (unpaired  t test; n = 4, 6 experimental 
sets; p = 0.3, p = 0.6), while a knockdown of syntaxin5 results in a 97% decrease in this rate 
(unpaired  t test; n = 6 experimental sets; p = 8 × 10 −8 ). Error bars represent standard error of the 
mean (SEM). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (C) Western blot analysis of siRNA knockdown 
of optineurin, myosin VI, VAMP7, and syntaxin5. 
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fusion event can be observed as a sudden, punctate fl ash of light in 
the TIRF fi eld. It is thus possible to quantify the number of individual 
fusion events in a given cell by counting the number of punctate 
fl ashes of light observed at the cell base using TIRF microscopy. 
 To determine the effects of an absence of myosin VI or optineu-
rin on vesicle fusion at the plasma membrane, we quantifi ed the 
total number of fusion events in sets of mock or siRNA knockdown 
cells monitored at specifi c, 5-min intervals between 25 and 60 min 
after AP21998 treatment. Still images of videos taken in the TIRF 
fi eld of mock, optineurin, myosin VI, or Rab8 knockdown cells are 
shown in  Figure 4A . Pink squares mark the sites of fusion events 
during a 20-s time-lapse movie. When compared with mock cells, 
knockdown of optineurin with a SMARTpool collection of four 
siRNA primers results in a 50% average decrease in the total num-
ber of fusion events, whereas knockdown of myosin VI with SMART-
pool primers results in a 38% average decrease ( Figure 4B ). Sup-
plemental Movies 1–3 provide a visual demonstration of this 
decrease in fusion events after a knockdown of myosin VI or 
optineurin. 
 To control for possible off-target effects, we performed the same 
study with individual siRNA primers for both optineurin and myosin 
VI. Knockdowns with two individual primers for optineurin result in 
very consistent 47% decreases in the total number of fusion events 
( Figure 4B ). Similarly, knockdowns with two individual primers for 
myosin VI result in consistent 34 and 37% decreases in the total 
number of fusion events ( Figure 4B ). These data indicate that the 
decrease in fusion events observed after a SMARTpool knockdown 
of optineurin or myosin VI is not simply an off-target effect of the 
siRNA primers. 
 We also measured fusion events at the plasma membrane in 
Rab8 knockdown cells ( Figure 4C ) to assess whether this protein, an 
optineurin-interacting protein and GTPase involved in post-Golgi 
membrane traffi cking, is required for secretory vesicle fusion at the 
plasma membrane. The results summarized in  Figure 4B show that 
loss of Rab8 expression has no signifi cant effect on the average 
number of fusion events and so indicate that this Rab protein is not 
required in the fi nal stages of the secretory pathway. Supplemental 
Movies 1 and 4 provide a visual demonstration of this similar level of 
fusion events in mock versus Rab8 knockdown cells. 
 An increased number of vesicles are docked 
in the 100–200-nm TIRF fi eld in cells depleted 
of myosin VI or optineurin 
 To test whether the decrease in fusion events after a knockdown of 
optineurin or myosin VI results in an increase in the number of 
docked vesicles present at the plasma membrane, we quantifi ed the 
total area in the TIRF fi eld occupied by docked vesicles in sets of 
10 mock and knockdown cells imaged at specifi c intervals between 
25 and 60 min after AP21998 addition. The top panel in  Figure 5A 
presents representative images of the TIRF fi eld of mock and knock-
down cells. Confocal spinning disc images of the plasma membrane 
at the base of sample mock and knockdown cells are presented 
in the bottom panel as a reference point for the observation of 
differences in vesicle content with higher  x - y resolution. 
 Knockdown of optineurin results in an 83% increase in the area 
of the TIRF fi eld occupied by docked vesicles and a knockdown of 
myosin VI similarly results in a 70% increase in this area, as com-
pared with mock cells ( Figure 5B ). In Rab8 knockdown cells, no sig-
nifi cant increase in the area of the TIRF fi eld occupied by docked 
vesicles is observed ( Figure 5B ). This increase in the relative propor-
tion of docked vesicles present within 100–200 nm of the plasma 
membrane after a knockdown of myosin VI or optineurin suggests a 
myosin VI with respect to GFP-tagged secretory cargo, fi xed cells 
transfected with an mCherry-myosin VI construct were labeled with 
a monoclonal antibody to GFP [cargo,  Figure 3A (a)] and a polyclonal 
antibody for mCherry [myosin VI construct,  Figure 3A (b)]. The high 
level of colocalization between myosin VI and cargo-containing 
secretory vesicles at the plasma membrane [ Figure 3A (c)] directly 
suggests a role for myosin VI in the later stages of the secretory 
pathway. Depletion of optineurin by siRNA knockdown does not af-
fect this colocalization of myosin VI and secretory vesicles at the 
plasma membrane (unpublished data). To examine the localization 
of optineurin with respect to secretory cargo, fi xed cells were la-
beled with a monoclonal antibody to GFP [cargo,  Figure 3B (a)] and 
a polyclonal antibody to optineurin [optineurin,  Figure 3B (b)]. This 
low-level colocalization of optineurin with specifi c secretory vesicles 
[ Figure 3B (c)] suggests a potential role for optineurin in the fi nal 
stages of secretion. 
 The number of secretory vesicle fusion events at the 
plasma membrane is decreased by a knockdown 
of myosin VI or optineurin 
 To examine the function of the myosin VI and optineurin associated 
with late-stage secretory cargo, we conducted TIRF microscopy ex-
periments with live cells. The use of TIRF to selectively illuminate the 
100–200-nm region nearest the plasma membrane at the base of a 
live cell increases the signal-to-noise ratio to such an extent that it is 
possible to visualize the fusion of individual, cargo-fi lled secretory 
vesicles with the plasma membrane ( Zenisek  et al. , 2000 ). Such fu-
sion events represent the formation of a small, aqueous channel or 
“fusion pore” between the membrane of a vesicle docked at the 
plasma membrane and the plasma membrane itself (Jahn and 
Sudhof,  1999 ). This fusion pore dilates to permit the release of se-
cretory proteins from the vesicle into the extracellular environment 
(Sorensen,  2009 ). In our study, the rapid, extracellular release of the 
fl uorescently tagged reporter construct during an individual vesicle 
 FIGURE 2:  Number of vesicles traveling between the Golgi and 
plasma membrane. (A) Illustration of vesicle numbering method. The 
image displays a cell in which one 6 μm × 6 μm region between the 
Golgi complex and the plasma membrane has been selected. For 
analysis, the total number of vesicles present in regions of this size and 
location were quantifi ed over the course of 1-min videos using vesicle 
tracking software. (B) Average number of vesicles in 6 μm × 6 μm 
regions between the Golgi and plasma membrane in mock, optineurin, 
or myosin VI knockdown cells. Data represent averages of the total 
number of vesicles in 6 μm × 6 μm regions placed in sets of fi ve cells 
imaged at specifi c intervals between 25 and 60 min after the addition 
of AP21998. There is no signifi cant difference in the number of vesicles 
present in these regions after a knockdown of optineurin (unpaired  t 
test; n = 3 experimental sets; p = 0.9) or a knockdown of myosin VI 
(unpaired  t test; n = 3 experimental sets; p = 0.7). Error bars represent 
SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
58 | L. M. Bond et al. Molecular Biology of the Cell
peak of the graph represents the formation 
of a fusion pore with the vesicular mem-
brane (“fusion”), and the downward slope 
of the graph represents the release of 
the fl uorescent reporter molecule through 
the expanded fusion pore. In such a full fu-
sion event, the average fl uorescent intensity 
in the seconds (−5 to −1) immediately prior 
to the fusion peak is characteristically higher 
than the average fl uorescent intensity in the 
seconds (+1 to +5) immediately following 
the fusion peak, refl ecting the fact that 
the fl uorescent reporter construct is fully 
released from the fused vesicle. 
 Four percent of the vesicles in mock 
cells exhibit a second type of fusion pat-
tern, in which a docked vesicle fl ashes 
briefl y and then remains present and fi lled 
with fl uorescent cargo beneath the plasma 
membrane ( Figure 6B , images). The behav-
ior of these vesicles fi ts the profi le of the 
“incomplete fusion events” previously ob-
served by patch amperometry or capaci-
tance recording ( Spruce  et al. , 1990 ;  Zhou 
 et al. , 1996 ;  Albillos  et al. , 1997 ). In these 
incomplete fusion events, vesicles dock, 
prime, form transient fusion pores with the 
plasma membrane, and then close these 
pores rather than expanding them for full 
cargo release (Sorensen,  2009 ). Quantita-
tive modeling of the average fl uorescent 
intensity in the area immediately surround-
ing an incomplete fusion event reveals a 
characteristic peak shape ( Figure 6B , graph) 
in which the average fl uorescent intensity 
in the seconds (−5 to −1) immediately prior 
to the fusion peak is lower than the average 
fl uorescent intensity in the seconds (+1 
to +5) immediately following the fusion peak, refl ecting an incom-
plete release of fl uorescent cargo. The color-coded boxes in Sup-
plemental Movies 1–4 highlight the appearance of full versus in-
complete fusion events as observed by live-cell TIRF microscopy. 
 To further characterize the exact role of myosin VI and optineurin 
in the later secretory pathway, we assessed whether the decrease in 
full fusion events at the plasma membrane after a knockdown of 
myosin VI or optineurin is accompanied by a corresponding increase 
in incomplete secretory vesicle fusion events. Still images of videos 
taken in the TIRF fi eld of mock, optineurin, myosin VI, and Rab8 
knockdown cells are shown in  Figure 6A . Blue squares mark the sites 
of full fusion events and red squares mark the sites of incomplete 
fusion events during a 20-s time-lapse movie. For our study, we 
quantifi ed the proportion of total vesicle fusion events that did not 
proceed to a full release of the fl uorescent reporter molecule (“pro-
portion of incomplete fusion events”) in sets of cells monitored at 
specifi c, 5-min intervals between 25 and 60 min after AP21998 treat-
ment ( Figure 6C ). Strikingly, cells in which optineurin has been 
knocked down with a SMARTpool primer collection or with individ-
ual primers have an eight- to ninefold higher proportion of incom-
plete fusion events than mock cells. Cells in which myosin VI has 
been knocked down with SMARTpool or individual primers also dis-
play a 1.6- to 1.7-fold increase in the proportion of incomplete fu-
sion events when compared with mock cells. Rab8 knockdown cells, 
role for myosin VI and optineurin in the fi nal, vesicle fusion stages of 
the secretory pathway. 
 The proportion of incomplete secretory vesicle fusion 
events at the plasma membrane is increased in myosin VI 
or optineurin knockdown cells 
 In our TIRF time-lapse movies, we observe two distinct types of exo-
cytic fusion events during the constitutive secretion of the reporter 
molecule ( Figure 6 ). The primary type (96% of fusion events in mock 
cells) can be visualized as a transient fl ash of spreading and then 
disappearing fl uorescent light ( Figure 6B , images) and fi ts the pro-
fi le of the “full fusion events” described in previous studies of vesicle 
fusion (Jahn and Sudhof,  1999 ; Steyer and Almers,  2001 ; Jackson 
and Chapman,  2006 ; Sorensen,  2009 ). These full fusion events oc-
cur in a series of stages: the secretory vesicle docks at the plasma 
membrane, the vesicle is primed as fusion machinery gathers, a 
small fusion pore is formed as the vesicle membrane and plasma 
membrane fuse to create an aqueous channel, and fi nally the fusion 
pore expands to permit rapid release of vesicle contents from the 
cell by diffusion (Jackson and Chapman,  2006 ). Quantitative model-
ing of the average fl uorescent intensity in the area immediately sur-
rounding a full fusion event reveals a characteristic peak shape ( Fig-
ure 6B , graph) in which the upward portion of the graph represents 
the movement of the vesicle toward the plasma membrane, the 
 FIGURE 3:  Colocalization of myosin VI and optineurin with secretory vesicles at the plasma 
membrane. (A) Sample images of the TIRF fi eld at the base of a HeLa cell (a) stably expressing 
the GFP-tagged reporter construct and (b) transfected with an mCherry-tagged myosin VI 
construct. Cells were fi xed 35 min after AP21998 addition and labeled by immunofl uorescence 
with a polyclonal antibody for mCherry and a monoclonal antibody to GFP. (c) A high level of 
colocalization is visible between myosin VI and secretory vesicles in the TIRF fi eld containing the 
reporter construct. Blue boxes highlight the region expanded for closer viewing in the top left of 
each panel. Bar, 10 μm. (B) Sample images of the TIRF fi eld at the base of a fi xed HeLa cell (a) 
stably expressing the GFP-tagged reporter construct and (b) labeled for endogenous optineurin. 
Cells were fi xed 35 min after AP21998 addition and labeled by immunofl uorescence with a 
polyclonal antibody to optineurin and a monoclonal antibody to GFP. (c) A low level of 
colocalization is visible between optineurin and the secretory vesicles in the TIRF fi eld. White 
arrows point out specifi c examples of colocalization and the blue boxes highlight the example 
expanded in the top left of each panel. Bar, 10 μm. 
Volume 22 January 1, 2011 Myosin VI and optineurin in secretion | 59 
ing of a GFP-tagged reporter molecule from 
the ER through the Golgi complex to the 
plasma membrane, we are able to establish 
roles for myosin VI and optineurin at dis-
crete stages of secretion. Specifi cally, our 
results indicate an unexpected function 
for myosin VI in ER to Golgi transport and 
a role for both myosin VI and optineurin 
in secretory vesicle fusion at the plasma 
membrane. 
 Role for myosin VI in ER-to-Golgi 
transport 
 The kinetic delay in ER-to-Golgi transport 
visible after a knockdown of myosin VI 
suggests a role for this protein in the early 
stages of secretion. It is possible that my-
osin VI plays a novel mechanistic role in 
this stage of the secretory pathway. 
Though microtubule-based transport is 
the classic mode of transport of COPII-
coated vesicles from ER exit sites (ERESs) 
to the central Golgi complex ( Palmer 
 et al. , 2005 ), a complementary role for the 
actin cytoskeleton in COPII vesicle trans-
port has been suggested (Disanza and 
Scita,  2008 ). Myosin VI proteins moving 
along such ERES-associated actin fi la-
ments could play a role in mediating 
COPII exit from the ER, tethering COPII 
vesicles near ERESs, or transporting these 
vesicles in shorter-range movements 
along actin fi laments before their longer-
range transport along microtubules. Alter-
natively, the kinetic delay that we note in 
ER-to-Golgi transport may be an indirect 
result of modifi cations in the actin cy-
toskeleton upon depletion of myosin VI. 
Myosin VI has been implicated in the or-
ganization of the actin cytoskeleton 
( Noguchi  et al. , 2006 ), and the bidirec-
tional transport of cargo between ERESs 
and the Golgi complex likely relies par-
tially on actin-based transport ( Lee  et al. , 
2004 ). Whether direct or indirect, our 
results suggest a novel infl uence of myosin VI on ER-to-Golgi 
secretion. 
 Golgi-to–plasma membrane transport 
 Interestingly, the number of vesicles budding and traveling away 
from the TGN is not changed by a myosin VI knockdown, despite 
the observed kinetic delay in ER-to-Golgi transport upon depletion 
of myosin VI. This fi nding suggests that the moderate reduction in 
transport rate between the ER and Golgi complex after myosin VI 
depletion is not a rate-limiting factor in the overall secretory path-
way and so does not affect the transport levels between the Golgi 
and the plasma membrane. 
 Myosin VI and optineurin are both associated with vesicular 
structures in the perinuclear region around the Golgi complex and 
have therefore been suggested to play a role in secretory vesicle 
formation or cargo sorting at the TGN (Buss and Kendrick-Jones, 
 2008 ). Our results, however, do not support a critical role for myosin 
however, show no signifi cant difference from mock cells in the pro-
portion of vesicle fusion events that do not proceed to completion. 
Supplemental Movies 1–4 provide a visual demonstration of the in-
crease in incomplete fusion events after a knockdown of myosin VI 
or optineurin and the unchanged proportion of incomplete fusion 
events after a knockdown of Rab8. The decrease in full fusion events 
and increase in incomplete fusion events observed after depletion 
of optineurin or myosin VI directly suggests a role for these proteins 
in the pore expansion stage necessary for full cargo release by se-
cretory vesicles at the plasma membrane. 
 DISCUSSION 
 Although a requirement for myosin VI and its interacting protein 
optineurin in protein secretion has been established using a variety 
of assays in different cell types, the exact molecular role of these 
proteins in the exocytic pathway is unknown. Using a unique live-cell 
secretion assay that allows visualization of the synchronized traffi ck-
 FIGURE 4:  Total number of vesicle fusion events at the plasma membrane. (A) Sample images 
of the TIRF fi eld of mock and knockdown cells with pink squares marking the sites of fusion 
events over the course of a 20-s movie. Bars, 10 μm. (B) Average total number of vesicle fusion 
events observed by TIRF microscopy at the base of sets of cells monitored at specifi c, 5-min 
intervals between 25 and 60 min after AP21998 addition. Knockdown of optineurin with 
SMARTpool primers (SP), individual primer 1, or individual primer 2 results in a 50, 47, or 47% 
decrease in the total number of vesicle fusion events, respectively (unpaired  t test; n = 4 sets of 
10 cells each [SP] or 4 sets of fi ve cells each [individual primers]; p = 9 × 10 −6 , p = 2 × 10 −5 , p = 1 × 
10 −5 ). Knockdown of myosin VI with SMARTpool primers (SP), individual primer 1, or individual 
primer 2 results in a 38, 34, or 37% decrease in the total number of vesicle fusion events, 
respectively (unpaired  t test; n = 5 sets of 10 cells each [SP] or 4 sets of fi ve cells each [individual 
primers]; p = 9 × 10 −5 , p = 7 × 10 −5 , p = 7 × 10 −5 ). Knockdown of Rab 8 has no signifi cant effect on 
the total number of vesicle fusion events (unpaired  t test; n = 3 sets of 10 cells each; p = 0.9). 
Error bars represent SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (C) Western blot analysis of siRNA 
knockdown of Rab8 with SMARTpool primers and of optineurin with individual primers 1 and 2. 
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 FIGURE 5:  Relative area of the TIRF fi eld occupied by vesicles. (A) Top, sample images of 
vesicles in the TIRF fi eld at the base of mock, optineurin knockdown, myosin VI knockdown, and 
Rab8 knockdown cells. Bottom, confocal images at the base of mock and knockdown cells as a 
reference for vesicle content at a higher  x - y resolution. Bar, 10 μm. (B) Relative average area of 
the TIRF fi eld occupied by docked vesicles. Volocity analysis software was used to calculate the 
total area in the TIRF fi eld occupied by fl uorescent vesicles in single plane images taken at 
specifi c intervals between 25 and 60 min after AP21998 addition to mock and knockdown cells. 
Knockdown of optineurin results in an 83% increase in the area occupied by vesicles as 
compared with mock cells (unpaired  t test; n = 3 sets of 10 cells; p = 0.008) and knockdown of 
myosin VI similarly results in a 70% increase in the area occupied by vesicles (unpaired  t test; n = 
3 sets of ten cells; p = 0.04). A knockdown of Rab8, however, has no signifi cant effect on the 
area in the TIRF fi eld occupied by vesicles (unpaired  t test; n = 3 sets of 10 cells; p = 0.2). Bar, 
SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
VI or optineurin in the basic mechanism of vesicle formation at the 
TGN, because we do not observe any change in the number of 
vesicles traveling from the TGN to the plasma membrane in myosin 
VI or optineurin knockdown cells. The perinuclear localization of 
myosin VI and optineurin may therefore be linked to a function in 
cargo sorting rather than vesicle formation at the TGN. This hypoth-
esis is supported by previous fi ndings that myosin VI and optineurin 
function with Rab8 in cargo sorting to the basolateral domain in 
polarized epithelial cells and to the dendritic surface in neuronal 
cells ( Huber  et al. , 1993a ;  Au  et al. , 2007 ). Because unpolarized 
HeLa cells do not sort cargo to specifi c 
plasma membrane domains, such cargo 
sorting defects could not be identifi ed for 
the reporter molecule used in this study. 
 Role for optineurin and myosin VI in 
fusion pore expansion at the plasma 
membrane 
 Using TIRF microscopy, we have demon-
strated colocalization of myosin VI and op-
tineurin with secretory vesicles at the plasma 
membrane and established that the ab-
sence of optineurin or myosin VI has a dra-
matic effect on the fi nal stages of the secre-
tory pathway. In myosin VI or optineurin 
knockdown cells, we observe a 35–50% de-
crease in the number of secretory vesicles 
fusing with the plasma membrane for pro-
tein release into the extracellular space. 
This reduction in the total number of fusion 
events is very similar to the previously re-
ported ∼50% decrease in constitutive se-
cretion of reporter molecules such as VSV-G 
or SEAP in optineurin or myosin VI siRNA 
knockdown cells or in fi broblasts isolated 
from the myosin VI knockout mouse 
( Sahlender  et al. , 2005 ;  Chibalina  et al. , 
2008 ). 
 The fact that our observed reduction in 
the total number of fusion events is accom-
panied by an increased number of docked 
vesicles beneath the plasma membrane fo-
cuses the secretory defect arising from a 
knockdown of myosin VI or optineurin to 
the fi nal stages of the secretory pathway 
(docking, priming, or vesicle fusion). Our 
detailed examination of the fusion defect 
demonstrates that knockdown of optineurin 
or myosin VI results specifi cally in an in-
crease in the proportion of incomplete fu-
sion events. This result would appear to link 
the defect to a change in the behavior of 
the fusion pore formed between the vesicle 
membrane and plasma membrane during 
the fi nal stages of secretion. Because the 
opening and closing of exocytic fusion 
pores is believed to be a dynamic and re-
versible process (Jackson and Chapman, 
 2006 ), our observed increase in instances of 
incomplete cargo release from fused vesi-
cles suggests that a knockdown of optineu-
rin or myosin VI either hinders the outward 
expansion of fusion pores during exocytosis or increases the fre-
quency of reversible closure of these pores. 
 Such involvement of an actin-based molecular motor in fusion 
pore mechanics is not without precedent. Myosin II has been shown 
to maintain an open fusion pore in secretory epithelial cells and a 
mutant form of myosin II hinders fusion pore expansion during se-
cretion in chromaffi n cells ( Neco  et al. , 2008 ; Bhat and Thorn,  2009 ). 
Related studies tie the role of myosin II in fusion pore mechanics 
closely to its interaction with the actin cytoskeleton (Becker and 
Hart,  1999 ;  Doreian  et al. , 2008 ;  Berberian  et al. , 2009 ), which has 
Volume 22 January 1, 2011 Myosin VI and optineurin in secretion | 61 
 FIGURE 6:  Full vs. incomplete fusion events at the plasma membrane. (A) Sample images of the 
TIRF fi eld of mock and knockdown cells with locations of full fusion events during a 20-s movie 
marked with blue squares and the incomplete fusion events with red squares. Bar, 10 μm. 
(B) Representative profi les of average intensity vs. relative time for localized regions containing 
full vs. incomplete fusion events. Before plotting, all intensities were corrected for 
photobleaching and normalized to a peak value of 1. The images display the fusing vesicle at the 
peak of the plot and at 1- and 5-s time points before and after this peak. (C) Average proportion 
of incomplete vesicle fusion events observed by TIRF microscopy at the base of sets of cells 
monitored at specifi c, 5-min intervals between 25 and 60 min after AP21998 addition. 
Knockdown of optineurin with SMARTpool primers (SP) results in a ninefold increase in the 
proportion of incomplete fusion events (unpaired  t test; n = 4 sets of 10 cells; p = 2 × 10 −5 ) and 
knockdown with individual primer 1 or individual primer 2 results in an eightfold increase 
(unpaired  t test; n = 4 sets of fi ve cells each; p = 6 × 10 −6 , p = 1 × 10 −6 ). Knockdown of myosin VI 
with SMARTpool primers (SP), individual primer 1, or individual primer 2 results in 1.7-, 1.6-, and 
1.7- fold increases in the percentage of incomplete vesicle fusion events, respectively (unpaired 
 t test; n = 5 sets of 10 cells each [SP] or 4 sets of fi ve cells each [individual primers]; p = 1 × 10 −4 , 
p = 0.003, p = 3 × 10 −5 ). Knockdown of Rab8 has no signifi cant effect on the proportion of 
incomplete fusion events (unpaired  t test; n = 3 sets of 10 cells; p = 0.4). Bar, SEM. *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001. 
itself been separately implicated in the regulation of fusion pore 
expansion and contraction ( Larina  et al. , 2007 ; Cingolani and Goda, 
 2008 ). Specifi cally, it has been suggested that myosin II and cortical 
actin together promote the increased mem-
brane tension necessary to expand the fu-
sion pore for full content release ( Berberian 
 et al. , 2009 ). Membrane remodeling through 
the interaction of myosin Ic and the actin 
cytoskeleton has been similarly shown to 
play a role in exocytic vesicle fusion in 
mouse adipocytes ( Bose  et al. , 2004 ) and in 
compensatory endocytic vesicle formation 
in  Xenopus laevis (Sokac et al.,  2006 ). 
 Though initiation of fusion at the plasma 
membrane is closely tied to the functioning 
of SNARE proteins, Sec1/Munc18 homo-
logues (SM proteins), and Rab proteins 
(Jahn and Sudhof,  1999 ; Stenmark,  2009 ; 
Jackson,  2010 ;  Pieren  et al. , 2010 ), the spe-
cifi c molecular mechanism regulating fusion 
pore expansion and closure remains to be 
determined. Several factors other than my-
osin II/myosin Ic and actin have also been 
implicated in the regulation of fusion pore 
mechanics, such as calcium concentration 
( Elhamdani  et al. , 2006 ), cholesterol levels 
( Wang  et al. , 2010 ), the SNARE-binding 
proteins complexin II ( Archer  et al. , 2002 ) 
and synaptotagmin ( Davis  et al. , 1999 ;  Rizo 
 et al. , 2006 ), and the GTPase dynamin 
( Tsuboi  et al. , 2002 ;  Jaiswal  et al. , 2009 ), but 
the interaction between these factors on a 
mechanistic level is presently unclear. Our 
study adds to the list of likely players in 
this process both optineurin and myosin VI. 
 The similar functional defects in secre-
tion after myosin VI or optineurin knock-
down (reduced secretion levels, increased 
proportion of docked vesicles at the plasma 
membrane, and increased number of in-
complete fusion events) suggest a coordi-
nated function for these proteins at the fu-
sion pore. As such, we propose a model 
whereby the optineurin and myosin VI pres-
ent on secretory vesicles at the plasma 
membrane function together in fusion pore 
regulation ( Figure 7 ). Given the high level of 
colocalization between myosin VI and se-
cretory vesicles in the TIRF fi eld, we suggest 
that myosin VI is recruited at an earlier stage 
to docked secretory vesicles, perhaps by 
binding to PtdIns(4,5)P 2 , a phospholipid 
known to function both in exocytosis (Wenk 
and De Camilli,  2004 ) and in the recruitment 
of myosin VI to clathrin-coated endocytic 
vesicles ( Spudich  et al. , 2007 ). On the basis 
of the low-level colocalization of optineurin 
with secretory vesicles in the TIRF fi eld, we 
suggest that optineurin is recruited to vesi-
cles immediately prior to fusion (possibly by 
the already present myosin VI) and binds to 
a yet-to-be-determined member of the fu-
sion pore machinery. The functional connection between huntingtin, 
a known binding partner of optineurin, and complexin II suggests 
huntingtin as one possible link between optineurin and the fusion 
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gression of POAG, a disease often caused 
by mutations in optineurin ( Joe  et al. , 2003 ; 
 Kuchtey  et al. , 2008 ). Patients with ALS, a 
disease causally linked to improper op-
tineurin function, also demonstrate abnor-
mal secretion of growth hormone and insu-
lin-like growth factor ( Maruyama et al. , 2010 ; 
 Pellecchia  et al. , 2010 ). Alteration in secre-
tion levels of brain natriuretic peptide has 
been shown to mark disease progression in 
hypertrophic cardiomyopathy, a disease 
linked to mutations in myosin VI ( Pieroni  et 
al. , 2007 ). Furthermore, it has been sug-
gested that the overexpression of myosin VI 
in prostate cancer cells enhances disease 
progression by increasing secretion of pro-
teins such as vascular endothelial growth 
factor ( Puri  et al. , 2009 ). Our study of the 
effects of myosin VI and optineurin on se-
cretion level modulation via fusion pore dy-
namics is therefore a new avenue for under-
standing the involvement of these proteins 
in disease malignancy. 
 MATERIALS AND METHODS 
 Antibodies 
 The following antibodies were used: rabbit 
polyclonal antibody to optineurin ( Sahlender 
 et al. , 2005 ); rabbit polyclonal antibody to 
myosin VI ( Buss  et al. , 1998 ), mouse monoclonal antibody to Rab8 
(BD Transduction Laboratories, Franklin Lakes, NJ) , mouse mono-
clonal antibody to VAMP7 ( Gordon  et al. , 2010 ), mouse monoclo-
nal antibody to syntaxin5 ( Williams  et al. , 2004 ), rabbit polyclonal 
antibody to Dab2 (Santa Cruz Biotechnology, Heidelberg, Ger-
many) , rabbit polyclonal antibody to calregulin (Santa Cruz Biotech-
nology), rabbit polyclonal antibody to DsRed (Clontech, Mountain 
View, CA) , and mouse monoclonal antibody to GFP (Invitrogen, 
Paisley, UK) . 
 Cell lines and expression constructs 
 The reporter construct secretion system was developed by Andrew 
Peden from the RPD Regulated Secretion/Aggregation Kit (Ariad 
Pharmaceuticals) as previously described ( Gordon  et al. , 2010 ). In 
short, eGFP (Clontech) was incorporated into the pC4S1-FM4-FCS-
hGH plasmid from this kit. The section of this plasmid containing the 
eGFP, signal sequence, aggregation domains, furin cleavage site, 
and human growth hormone was then transferred into a retroviral 
vector (pQCXIP; Clontech). The resulting pQCXIP-S1-eGFP-FM4-
FCS-hGH construct was used to generate a stable secretion cell line 
in HeLa-M cells. To initiate secretion during microscopy studies, 
cells were treated with a 1-μM solution of AP21998, a ligand which 
solubilizes the reporter molecule by interrupting the interaction of 
its aggregation domains. 
 The GalT-mRFP plasmid used in this work was provided by G. 
Patterson (Lippincott-Schwartz Lab, National Institute of Child 
Health and Human Development, Bethesda, MD) . 
 Cell culture and transfection 
 The cell line used in this study was maintained at 37°C in 
Dulbecco’s modifi ed Eagle medium (Invitrogen) supplemented 
with 10% fetal calf serum (FCS), 2-mM  L -glutamine, and penicillin/
streptomycin (Sigma-Aldrich, Dorset, UK) . To maintain selection 
pore machinery ( Edwardson  et al. , 2003 ). In light of our functional 
TIRF studies, we suggest that that the fusion pore–bound optineurin 
functions with the myosin VI previously recruited to docked secretory 
vesicles to anchor the fusion pore to the actin cytoskeleton. The 
movement of optineurin-bound myosin VI toward the inward-di-
rected minus ends of actin fi laments at the plasma membrane would 
thereby provide the tension necessary for stabilization and expan-
sion of the fusion pore. Overall, we propose a model in which op-
tineurin and myosin VI serve as one interface between the fusion 
pore regulatory machinery and the tension-providing modulations 
of the actin cytoskeleton. 
 It is important to note that this model provides only one possibil-
ity for the function of myosin VI and optineurin in fusion pore forma-
tion. Given that myosin VI and optineurin colocalize with cargo-fi lled 
vesicles at very different levels and that myosin VI and optineurin 
knockdown cells show proportionally different increases in incom-
plete fusion events, it is also possible that these proteins function 
separately in the mechanism of fusion pore expansion and closure. 
Such independent functionality would explain the lack of effect of a 
Rab8 knockdown on the number and type of secretory fusion events 
at the plasma membrane, which suggests that the Rab8–optineurin–
myosin VI complex shown to be required for cargo sorting in polar-
ized epithelial cells ( Au  et al. , 2007 ) does not function in fusion pore 
expansion. 
 The biomedical implications of the involvement of myosin VI and 
optineurin in fusion pore dynamics are very interesting; recent work 
points to the emerging fusion pore regulation machinery as a critical 
control point for the regulation of release of the contents of secre-
tory vesicles (Thorn,  2009 ). It is possible, therefore, that the malig-
nant progression of diseases aggravated by mutations in optineurin 
or myosin VI may stem from improper regulation of levels of secre-
tory cargo release. For example, secretory defects in myocilin and 
angiopoietin-like 7 protein secretion have been linked to the pro-
 FIGURE 7:  Suggested model for involvement of optineurin and myosin VI in fusion pore 
expansion. Fusion pore formation and regulation are presently tied to certain SNARE proteins 
and Rab GTPases, Sec1/Munc18 homologues (SM proteins), the SNARE-binding proteins 
complexin II and synaptotagmin, the GTPase dynamin, and the molecular motors myosin II and 
myosin 1c. Our data suggest that the myosin VI and optineurin present on secretory vesicles at 
the plasma membrane also function at the fusion pore. We propose that optineurin binds an 
unidentifi ed protein associated with the fusion pore, in addition to the myosin VI previously 
recruited to docked secretory vesicles. In this manner, a functional link is formed between the 
fusion pore and the actin cytoskeleton associated with myosin VI. This link permits the use of the 
tensile forces created by movement of myosin VI toward the inward-facing minus ends of actin 
fi laments to stabilize or expand the fusion pore. In short, we propose that optineurin and myosin 
VI regulate fusion pore dynamics by acting as a link between the fusion pore and the tensile 
forces of the actin cytoskeleton. 
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prepare protein samples for this process, mock and knockdown cells 
were resuspended in urea/β-mercaptoethanol loading buffer (2% 
SDS, 30% glycerol, 1 M β-mercaptoethanol, 6 M urea, 0.125 M Tris, 
pH 6.8, and 0.01% bromophenol blue), lysed, and then boiled for 
4 min. SDS–PAGE of protein samples was carried out on 10 or 12% 
polyacrylamide gels as previously described (Matsudaira and Bur-
gess,  1978 ). A Dual Color Precision Plus Protein Standard (Biorad, 
Bath, UK) was loaded at either end of the gel as a reference for com-
parison of molecular weights of protein samples. After electrophore-
sis, a semidry blotter was used to transfer proteins from the SDS-
polyacrylamide gel to a Protran nitrocellulose membrane with a pore 
size of 0.45 μm (Schleicher and Schuell Bioscience, London, UK) . 
The membrane was incubated in 10% wt/vol Marvel milk powder in 
1× PBS to block nonspecifi c binding sites. Individual sections of 
membrane containing specifi c proteins of interest were then incu-
bated with primary and then secondary antibodies diluted in 1% wt/
vol Marvel milk powder in 1× PBS. An enhanced chemiluminses-
cence reaction kit (GE Healthcare, Amersham, UK) was used to 
detect protein bands in the membrane. 
 Spinning disc microscopy 
 For spinning disc microscopy studies, cells were grown on 25-mm 
round coverslips (VWR International, Lutterworth, UK) and imaged 
at 37ºC in CO 2 -independent medium (Invitrogen). Images were ob-
tained on a Zeiss Cell Observer SD microscope (Carl Zeiss) using a 
63× or 100× lens and 2 × 2 binning. Images were acquired with a 
Hamamatsu Photonics EM-CCD Digital Camera (Hamamatsu City, 
Japan) and AxioVision imaging software (Carl Zeiss). 
 Volocity analysis software (Improvision, Cambridge, UK) was 
used to quantify the rate of transfer of the reporter molecule from 
the ER to the Golgi complex in spinning disc videos. 
 TIRF microscopy 
 For live-cell TIRF microscopy studies, cells were grown on 25-mm 
round coverslips (VWR International) and imaged at 37ºC in CO 2 -
independent medium (Invitrogen). Imaging was conducted on a 
Zeiss TIRF 3 microscope (Carl Zeiss). During each TIRF experiment, 
a 488-nm argon laser was directed at the coverslip at an angle 
greater than the critical angle of the laser line. The resulting total 
internal refl ection of the laser line created an evanescent fi eld in the 
100–200-nm region of the sample closest to the coverslip. 
 Images were acquired with a 100× lens, Hamamatsu Photonics 
EM-CCD digital camera (Hamamatsu Photonics), and AxioVision 
Imaging Software (Carl Zeiss). Samples were imaged in 5-min inter-
vals at maximum speed (approximately 4 frames/s) at points 25, 32, 
39, 46, and 53 min after the addition of 1 μM AP21998. Exactly two 
cells were imaged at each time point to ensure that the distribution 
of cells over the course of the imaging period was equivalent 
between mock and knockdown data sets. 
 The total area covered by docked vesicles at the base of a given 
cell was calculated from the fi rst frame of each movie using Volocity 
Analysis software (Improvision). This software was also used to pro-
fi le fl uorescent intensity over time at the sites of individual full or 
incomplete fusion events. 
 Vesicle tracking program 
 The number of vesicles traveling in 6 μm × 6 μm regions between 
the  trans- Golgi and the plasma membrane in spinning disc videos 
was quantifi ed using a customized particle tracking program. This 
program was modifi ed by C.A. Combs (Light Microscopy Core Fa-
cility at the National Heart, Lung, and Blood Institute) and R. Kling 
(Ronn Kling Consulting, Warrenton, VA) from open-source particle 
for cells containing the pQCXIP-S1-eGFP-FM4-FCS-hGH construct, 
this medium was also supplemented with puromycin (1.66 μg/ml). 
 Transfection of the GalT-mRFP or myosin VI–mCherry plasmids 
into tissue culture cells was executed according to the instructions 
provided by the manufacturer of the FuGENE transfection reagent 
(Roche Diagnostics, Welwyn Garden City, UK) . Prior to transfection, 
cells were grown to 50% confl uence on a six-well tissue culture tray 
(Greiner Bio-One, Stonehouse, UK) . Two micrograms of plasmid 
DNA and 6 μl of FuGENE transfection reagent diluted in 95 μl 
of Optimem I medium (Invitrogen) were used for each given trans-
fection in one well of the six-well tray. 
 Immunofl uorescence 
 For immunofl uorescence experiments, cells transfected 24 h prior 
with the appropriate constructs were treated with AP21998 for 
35 min, fi xed with 4% paraformaldehyde in phosphate-buffered sa-
line (PBS) for 20 min, permeabilized in 0.2% Triton X-100 in PBS for 
5 min, and blocked in 1% bovine serum albumin in PBS for 30 min. 
After blocking, cells were incubated with primary antibodies (poly-
clonal antibody to DsRed (Clontech) or polyclonal antibody to op-
tineurin; monoclonal antibody to GFP [Invitrogen]) and then with 
secondary antibodies (goat anti–rabbit IgG coupled with Alexa 555; 
goat anti–mouse IgG coupled with Alexa 488 [Invitrogen]). After 
washing, cells were mounted on glass slides with Prolong Gold 
Antifade Mounting Reagent (Molecular Probes, Invitrogen, United 
Kingdom) and imaged on a Zeiss TIRF 3 microscope (Carl Zeiss, 
Welwgn Garden City, UK) . 
 RNAi experiments 
 ON-TARGET plus SMARTpool mixtures of four individual primers 
(Dharmacon, Cramlington, UK) were used for depletion of myosin 
VI, optineurin, and Rab8. Individual primers to myosin VI (MVI 1, 
5′-CAUUGUAUCUGGAGAAUCAUU-3′; MVI 2, 5′-ACAUUCU-
GAUUGCAGUGAAUU-3′) and optineurin (Optn 1, 5′-CUUCGAA-
CAUGAGGAGUUA-3′; Optn 2, 5′-CUAAUGGCCUUGAGUCAUG-3′) 
were used to verify results and control for off-target effects. 
 For effi cient siRNA knockdown of myosin VI, optineurin, or Rab8, 
we used a double-knockdown protocol in which cells were trans-
fected with siRNA primers on days 1 and 3 using Oligofectamine (In-
vitrogen) according to the manufacturer’s instructions. Before siRNA 
knockdown, cells were grown to 70% confl uence in a six-well tray. For 
each knockdown, siRNA primers were diluted in Optimem I and 
transfected into individual wells of the six-well tray at a fi nal concen-
tration of 90 nM. The effectiveness of the knockdown was checked by 
immunoblotting on day 4 and effi ciently depleted cells were imaged 
on day 5. A similar double-knockdown protocol was used for deple-
tion of syntaxin5, but transfections were conducted with a single 
Dharmacon siRNA primer (5′-GGACAUCAAUAGCCUCAAC-3′) at a 
40-μM fi nal concentration using Lipofectamine 2000 (Invitrogen). 
 VAMP7 was depleted in a single-hit siRNA transfection protocol 
with a single Dharmacon primer (5′-GAACCUCAAGCUCACUAUU-3′) 
at a fi nal concentration of 90 nM using Oligofectamine. The effec-
tiveness of the knockdown was checked by immunoblotting on day 
3 and effi ciently depleted cells were imaged on day 4. 
 Mock-transfected cells were treated with the same mixture 
of Oligofectamine/Lipofectamine 2000 in Optimem I as siRNA-
transfected cells, but the solution used for these mock cells 
contained no siRNA. 
 Immunoblotting 
 Immunoblotting was used to assess whether individual proteins had 
been effi ciently depleted by our siRNA knockdown protocol. To 
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 Individual images were processed in Adobe Photoshop, and fi gures 
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